<600 MET-min n=98 | ≥600 MET-min n=283 | Total sample n=381 | |
Demographic characteristics | |||
Age (years) | 62.2±9.8 | 62.4±9.8 | 62.4±9.9 |
Gender* | |||
Man Woman | 45 (45.9%) 53 (54.1%) | 163 (57.6%) 120 (42.4%) | 208 (54.6%) 173 (45.4%) |
Marital status | |||
Single Married De facto (unmarried cohabitation) Divorced Widowed Other | 9 (9.2%) 67 (68.4%) 3 (3.1%) 8 (8.2%) 7 (7.1%) 4 (4.1%) | 26 (9.2%) 208 (73.5%) 12 (4.2%) 16 (5.7%) 18 (6.4%) 3 (1.1%) | 35 (9.2%) 275 (72.2%) 15 (3.9%) 24 (6.3%) 25 (6.6%) 7 (1.8%) |
Country of birth | |||
Australia | 76 (77.6%) | 218 (77%) | 294 (77.2%) |
BMI (kg/m2)** | 34.7±7.4 | 31.0±7.7 | 32.0±7.8 |
Underweight Normal range Overweight Obese | 0 (0%) 7 (7.1%) 27 (27.6%) 64 (65.3%) | 0 (0%) 53 (18.7%) 101 (35.7%) 129 (45.6%) | 0 (0%) 60 (15.7%) 128 (33.6%) 193 (50.7%) |
Education | |||
Year 10 or below Year 12 Vocational Tertiary | 16 (16.3%) 12 (12.2%) 33 (33.7%) 37 (37.8%) | 36 (12.7%) 27 (9.5%) 102 (36.0%) 118 (41.7%) | 52 (13.6%) 39 (10.2%) 135 (35.4%) 155 (40.7%) |
Employment | |||
Full time Part time Retired Not working | 29 (29.6%) 11 (11.2%) 45 (45.9%) 13 (13.3%) | 64 (22.6%) 49 (17.3%) 148 (52.3%) 22 (7.8%) | 93 (24.4%) 60 (15.7%) 193 (50.7%) 35 (9.2%) |
Household income (annual) | |||
Up to $20 000 $20 000–$40 000 $40 000–$60 000 $60 000–$100 000 Above $100 000 | 18 (18.4%) 33 (33.7%) 9 (9.2%) 20 (20.4%) 18 (18.4%) | 46 (16.3%) 69 (24.4%) 52 (18.4%) 56 (19.8%) 60 (21.2%) | 64 (16.8%) 102 (26.8%) 61 (16.0%) 76 (19.9%) 78 (20.5%) |
Psychosocial characteristics | |||
Depressive symptoms (WHO-5) | |||
Total score** Impaired well-being (<13)** | 12.3±5.7 53 (54.1%) | 15.8±5.4 74 (26.1%) | 14.9±5.7 127 (33.3%) |
Self-efficacy (BARSE) total score** | 4.3 (3.2, 5.4) | 6.6 (4.8, 8.2) | 5.8 (4.1, 7.6) |
Clinical characteristics | |||
Diabetes duration (years) | 8.7±9.6 | 8.3±7.4 | 8.4±8.0 |
HbA1c, % (mmol/mol) (n=252) | 7.1±1.2 (54±5) | 7.1±4.8 (54±29) | 7.1±4.3 (54±23) |
Diabetes management | |||
Insulin treatment Non-insulin treatment | 27 (27.6%) 71 (72.4%) | 63 (22.3%) 220 (77.7%) | 90 (23.6%) 291 (76.4%) |
Diabetes comorbidities* | |||
Per participant Total ≥1 comorbidity | 1 (0, 2) 56 (57.1%) | 0 (0, 1) 129 (45.6%) | 0 (0, 1) 184 (48.3%) |
*p<0.05; **p<0.01.
†All data are mean±SD, median (IQR) or n (%).
BARSE, Barriers Self-Efficacy; BMI, body mass index.